与激素变化相关的胃内球囊治疗对体重减轻、血清代谢、炎症和肝脏参数的有益影响

A. Swidnicka-Siergiejko, E. Wróblewski, H. R. Hady, Dagmara Bogdanowska-Charkiewicz, A. Dabrowski
{"title":"与激素变化相关的胃内球囊治疗对体重减轻、血清代谢、炎症和肝脏参数的有益影响","authors":"A. Swidnicka-Siergiejko, E. Wróblewski, H. R. Hady, Dagmara Bogdanowska-Charkiewicz, A. Dabrowski","doi":"10.25121/pnm.2018.31.3.138","DOIUrl":null,"url":null,"abstract":"Introduction. Beneficial effect of intragastric balloon (IGB) on weight loss and obesityrelated complications is still questionable and may be related to serum hormonal changes. Aim. The aim of the study was to assess the safety and benefits of IGB therapy associated with hormonal changes in peripheral blood. Material and methods. This was a prospective, observational study of 25 obese patients treated with an IGB with assessment of safety, weight loss, gastroesophageal reflux, serum laboratory tests, and circulating leptin and omentin. The consent of bioethical committee of Medical University of Bialystok, as well as written consent from all subjects were obtained. The study was supported by the Polish National Science Center grant No. N N402 456839. Results. A six-month IGB therapy resulted in a significant BMI decrease. The mean % total body weight loss at 6 months was 15.55 ± 8.96 and did not significantly change at 12 months. A 25% excess weight loss was achieved by 52 and 56% patients at 6 and 12 months, respectively. The therapy decreased mean levels of aminotransferases, glucose, C-reactive protein, hemoglobin A1c, and insulin resistance (HOMA-IR). Patients with % excess weight loss less than < 25 had significantly higher levels of leptin and lower levels of omentin. Leptin levels correlated with HOMA-IR, insulin, and alanine aminotransferase levels. Omentin levels correlated positively with HDL-cholesterol and negatively with alanine aminotransferase. Reflux esophagitis was found in 5 and 3 patients before and after therapy, respectively. The frequency of typical reflux symptoms did not differ significantly before and after therapy. There were no serious adverse events except one partial balloon deflation found on the day of its planned removal. Up to 80% patients were satisfied with therapy. Conclusions. IGB therapy is a safe and effective weight loss procedure and its beneficial effects on weight loss and several serum metabolic and liver function parameters are associated with hormonal changes.","PeriodicalId":206045,"journal":{"name":"Postępy Nauk Medycznych","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Beneficial effects of intragastric balloon therapy associated with hormonal changes on weight loss and serum metabolic, inflammatory and liver parameters\",\"authors\":\"A. Swidnicka-Siergiejko, E. Wróblewski, H. R. Hady, Dagmara Bogdanowska-Charkiewicz, A. Dabrowski\",\"doi\":\"10.25121/pnm.2018.31.3.138\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction. Beneficial effect of intragastric balloon (IGB) on weight loss and obesityrelated complications is still questionable and may be related to serum hormonal changes. Aim. The aim of the study was to assess the safety and benefits of IGB therapy associated with hormonal changes in peripheral blood. Material and methods. This was a prospective, observational study of 25 obese patients treated with an IGB with assessment of safety, weight loss, gastroesophageal reflux, serum laboratory tests, and circulating leptin and omentin. The consent of bioethical committee of Medical University of Bialystok, as well as written consent from all subjects were obtained. The study was supported by the Polish National Science Center grant No. N N402 456839. Results. A six-month IGB therapy resulted in a significant BMI decrease. The mean % total body weight loss at 6 months was 15.55 ± 8.96 and did not significantly change at 12 months. A 25% excess weight loss was achieved by 52 and 56% patients at 6 and 12 months, respectively. The therapy decreased mean levels of aminotransferases, glucose, C-reactive protein, hemoglobin A1c, and insulin resistance (HOMA-IR). Patients with % excess weight loss less than < 25 had significantly higher levels of leptin and lower levels of omentin. Leptin levels correlated with HOMA-IR, insulin, and alanine aminotransferase levels. Omentin levels correlated positively with HDL-cholesterol and negatively with alanine aminotransferase. Reflux esophagitis was found in 5 and 3 patients before and after therapy, respectively. The frequency of typical reflux symptoms did not differ significantly before and after therapy. There were no serious adverse events except one partial balloon deflation found on the day of its planned removal. Up to 80% patients were satisfied with therapy. Conclusions. IGB therapy is a safe and effective weight loss procedure and its beneficial effects on weight loss and several serum metabolic and liver function parameters are associated with hormonal changes.\",\"PeriodicalId\":206045,\"journal\":{\"name\":\"Postępy Nauk Medycznych\",\"volume\":\"2 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Postępy Nauk Medycznych\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25121/pnm.2018.31.3.138\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Postępy Nauk Medycznych","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25121/pnm.2018.31.3.138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

介绍。胃内球囊(IGB)对减肥和肥胖相关并发症的有益作用仍然值得怀疑,可能与血清激素变化有关。的目标。该研究的目的是评估与外周血激素变化相关的IGB治疗的安全性和益处。材料和方法。这是一项前瞻性观察性研究,25名肥胖患者接受IGB治疗,评估安全性、体重减轻、胃食管反流、血清实验室检查和循环瘦素和网膜。获得了比亚韦斯托克医科大学生物伦理委员会的同意以及所有受试者的书面同意。这项研究是由波兰国家科学中心资助的。n402 456839。结果。六个月的IGB治疗导致BMI显著下降。6个月时的平均体重下降百分比为15.55±8.96,12个月时无显著变化。在6个月和12个月时,分别有52%和56%的患者体重减轻了25%。治疗降低了转氨酶、葡萄糖、c反应蛋白、血红蛋白A1c和胰岛素抵抗(HOMA-IR)的平均水平。体重减轻%小于25的患者瘦素水平明显升高,网膜水平明显降低。瘦素水平与HOMA-IR、胰岛素和丙氨酸转氨酶水平相关。Omentin水平与hdl -胆固醇呈正相关,与丙氨酸转氨酶负相关。治疗前后分别有5例和3例出现反流性食管炎。治疗前后典型反流症状发生频率无显著差异。没有严重的不良事件,除了在计划取出气球的当天发现了一个部分气球收缩。高达80%的患者对治疗满意。结论。IGB治疗是一种安全有效的减肥方法,其有益的减肥效果和一些血清代谢和肝功能参数与激素变化有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Beneficial effects of intragastric balloon therapy associated with hormonal changes on weight loss and serum metabolic, inflammatory and liver parameters
Introduction. Beneficial effect of intragastric balloon (IGB) on weight loss and obesityrelated complications is still questionable and may be related to serum hormonal changes. Aim. The aim of the study was to assess the safety and benefits of IGB therapy associated with hormonal changes in peripheral blood. Material and methods. This was a prospective, observational study of 25 obese patients treated with an IGB with assessment of safety, weight loss, gastroesophageal reflux, serum laboratory tests, and circulating leptin and omentin. The consent of bioethical committee of Medical University of Bialystok, as well as written consent from all subjects were obtained. The study was supported by the Polish National Science Center grant No. N N402 456839. Results. A six-month IGB therapy resulted in a significant BMI decrease. The mean % total body weight loss at 6 months was 15.55 ± 8.96 and did not significantly change at 12 months. A 25% excess weight loss was achieved by 52 and 56% patients at 6 and 12 months, respectively. The therapy decreased mean levels of aminotransferases, glucose, C-reactive protein, hemoglobin A1c, and insulin resistance (HOMA-IR). Patients with % excess weight loss less than < 25 had significantly higher levels of leptin and lower levels of omentin. Leptin levels correlated with HOMA-IR, insulin, and alanine aminotransferase levels. Omentin levels correlated positively with HDL-cholesterol and negatively with alanine aminotransferase. Reflux esophagitis was found in 5 and 3 patients before and after therapy, respectively. The frequency of typical reflux symptoms did not differ significantly before and after therapy. There were no serious adverse events except one partial balloon deflation found on the day of its planned removal. Up to 80% patients were satisfied with therapy. Conclusions. IGB therapy is a safe and effective weight loss procedure and its beneficial effects on weight loss and several serum metabolic and liver function parameters are associated with hormonal changes.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信